<?xml version="1.0" encoding="UTF-8"?>
<p id="Par14">Cisplatin was administered at 100 mg/m
 <sup>2</sup> on day 1, 22, and 43 of radiotherapy. Cisplatin dose reductions or delays were based on a predefined toxicity criterion, which is available in Additional file 
 <xref rid="MOESM1" ref-type="media">1</xref>: Methods. Considering the maximum tolerated dose of famitinib was 25 mg for advanced solid malignancy [
 <xref ref-type="bibr" rid="CR28">28</xref>], we chose an initial dose of 12.5 mg. If two out of three patients had a DLT at 12.5 mg, the concurrent cisplatin dose was reduced to 80 mg/m
 <sup>2</sup> for the remaining patients.
</p>
